What are the criteria for a valid FibroScan (transient elastography) in adult patients?

Criteria for Valid FibroScan Measurements

A valid FibroScan requires at least 10 successful measurements with an interquartile range (IQR) to median ratio ≤30%, though measurements with IQR/M >30% can still be considered reliable if the liver stiffness value is <7.1 kPa 1.

Quality Criteria Framework

The validity of transient elastography measurements is determined by three key parameters that must be assessed together:

Traditional Reliability Criteria

• Minimum 10 valid measurements obtained
• Success rate >60%
• IQR/median ratio ≤0.30 (or ≤30%)

These traditional criteria identify approximately 71.6% of measurements as reliable 1, 2.

Updated Reliability Classification

More recent evidence has refined these criteria into a three-tier system that increases the proportion of usable measurements to 83.2% without compromising diagnostic accuracy 2:

Very Reliable Measurements:

• IQR/M <0.1 (or <10%)

Reliable Measurements:

• IQR/M ≤0.3 when liver stiffness is any value, OR
• IQR/M >0.3 if liver stiffness <7.1 kPa

Poorly Reliable (Invalid) Measurements:

• IQR/M >0.3 (or >30%) AND liver stiffness ≥7.1 kPa

This updated classification recognizes that higher variability is acceptable at lower stiffness values, where the clinical implications are less significant 2.

Technical Requirements

Probe Selection and Measurement Depth

• M-probe: Measures 25-65 mm below skin surface in the 9th-11th intercostal space
• XL-probe: Measures 35-75 mm below skin surface, used in obese patients
• Using both probes reduces failure rate to <5% 1, 3

Pre-Examination Requirements

Critical timing considerations:

• Fasting status: Patient must be fasting for 2-3 hours before examination 1
• Measurements should not be performed during acute hepatitis or within hours of food intake

Common Causes of Invalid Measurements

Patient Factors Associated with Failure or Poor Reliability

High-risk patient characteristics (when all present, failure rate reaches 58.5%) 4:

• Female gender (OR 1.32)
• Age >50 years (OR 2.04)
• BMI >27.7 kg/m² (OR 2.89)
• Weight >77 kg (OR 2.17)
• Height <162 cm (OR 1.26)

Obesity is the single most important factor, with failure/unreliability rates of 49.5% when BMI ≥30 kg/m² 4.

Clinical Conditions That Invalidate Measurements

Even technically adequate measurements may be inaccurate in these situations 1:

• Acute hepatitis (active inflammation)
• Recent alcohol consumption
• Congestive heart failure
• Extrahepatic cholestasis
• Ascites (can cause complete failure or false readings)

Additional Confounding Factors

• Elevated aminotransferases: Independent confounder affecting correlation with fibrosis stage 2
• Liver disease etiology: Different diseases require different cutoff values 2
• Operator experience: Reliability varies by operator, emphasizing need for adequate training 5

Practical Algorithm for Validity Assessment

Step 1: Verify minimum technical requirements

• ≥10 valid measurements obtained
• Success rate >60%

Step 2: Calculate IQR/median ratio

• If IQR/M ≤0.30: Measurement is valid
• If IQR/M >0.30: Proceed to Step 3

Step 3: Apply stiffness-dependent criteria

• If liver stiffness <7.1 kPa: Measurement is still valid
• If liver stiffness ≥7.1 kPa: Measurement is poorly reliable and should not be used

Step 4: Exclude clinical contraindications

• Confirm patient fasted 2-3 hours
• Rule out acute hepatitis, recent alcohol use, heart failure, cholestasis

Critical Pitfalls to Avoid

Do not use measurements when:

• IQR/M >30% with stiffness ≥7.1 kPa, even if 10 measurements obtained
• Patient has ascites (consider alternative methods like MRE)
• Performed within 2-3 hours of eating
• During acute hepatic inflammation or decompensated heart failure

Operator-dependent issues:

• Inadequate training is a significant source of unreliable results 5
• Operator experience matters more than the number of scans performed
• Consider repeat measurement by experienced operator if initial results are borderline

The overall failure rate with proper technique and patient selection should be approximately 1.6%, with poorly reliable measurements in only 4.9% of remaining patients 5.